Sensitizing drug-resistant cancer cells from blood using microfluidic electroporator.
Direct assessment of patient samples holds unprecedented potential in the treatment of cancer. Circulating tumor cells (CTCs) in liquid biopsies are a rapidly evolving source of primary cells in the clinic and are ideal candidates for functional assays to uncover real-time tumor information in real-...
Main Authors: | Hyun Woo Sung, Sung-Eun Choi, Chris H Chu, Mengxing Ouyang, Srivathsan Kalyan, Nathan Scott, Soojung Claire Hur |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0264907 |
Similar Items
-
Sensitizing drug-resistant cancer cells from blood using microfluidic electroporator
by: Hyun Woo Sung, et al.
Published: (2022-01-01) -
Inertial Microfluidics Enabling Clinical Research
by: Srivathsan Kalyan, et al.
Published: (2021-03-01) -
Editorial for the Special Issue on Inertial Microfluidics
by: Soojung Claire Hur, et al.
Published: (2021-05-01) -
Microfluidic Screening of Electric Fields for Electroporation
by: Ge, Zhifei, et al.
Published: (2016) -
Microfluidics based electroporation for inactivation of microorganisms
by: Pudasaini, Sanam
Published: (2020)